Patient Advocacy Group Funding

Amgen partners with patient advocacy groups for the benefit of patients and in a way that is true to the Industry Codes of Practice and Amgen's policy. Amgen is committed to making public the scope of its partnerships in the UK to increase transparency. This includes stating the amount of funding that Amgen provides each year to each organisation.

Below you can find more information about all of the projects and associated funding for each year.

2023 Funding Overview

2022 Funding Overview

2021 Funding Overview